ADIL
Adial Pharmaceuticals, Inc.Healthcare · $13M market cap
Verdict
We can't put a fair value on ADIL right now. It looks like a preferred share, note or other security rather than ordinary common stock. The figures we receive belong to the parent company, so they can't value this security.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow ADIL
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Oct 28, 2026: no open-market purchases and 7 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about ADIL
Are insiders buying ADIL?
Since Oct 28, 2026: no open-market purchases and 7 other filings (stock awards, tax withholding and similar).
How can I check ADIL's value myself?
Use the free Sticker Price calculator, already filled with ADIL's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Biotechnology
About Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 28, 2026. How the Payback Price works